Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes-Reference-Cited by-同舟云学术

Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes

Published:2018-10-10 Issue:6 Volume:14 Page:509-517
ISSN:1573-3998
Container-title:Current Diabetes Reviews
language:en
Short-container-title:CDR

Author:

Minze Molly G.¹,Will Kayley J.¹,Terrell Brian T.¹,Black Robin L.²,Irons Brian K.³

Affiliation:

1. Department of Pharmacy Practice, Ambulatory Care Division, School of Pharmacy, Texas Tech University Health Sciences Center, 1718 Pine Street, Abilene, Texas 79601, TX, United States

2. Department of Pharmacy Practice, Ambulatory Care Division, School of Pharmacy, Texas Tech University Health Sciences Center, 4500 S. Lancaster Building 7, Dallas, Texas 75216, TX, United States

3. Department of Pharmacy Practice, Ambulatory Care Division, School of Pharmacy, Texas Tech University Health Sciences Center, 3601 4th Street (MS 8162), Lubbock, Texas 79430, TX, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects;Frontiers in Pharmacology;2024-06-14

2. Dapagliflozin-Induced Erythrocytosis in Chronic Kidney Disease: A Rare Occurrence;Cureus;2024-04-23

3. Therapeutic effects of anti-diabetic drugs on traumatic brain injury;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-02

4. The Role of Autophagy in Type 2 Diabetic Kidney Disease Management;Cells;2023-11-23

5. WITHDRAWN: Impact of Dapagliflozin on insulin secretory function and serum adipokine expression levels in patients with primary diagnosis of type 2 diabetes mellitus;Contemporary Clinical Trials Communications;2023-06